Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 3,467 shares at $120.97 ($419K) on 2013-08-29, disclosed to the SEC on 2013-09-03.
Open-market sale of $419k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.97 | 2,144 | $259K | 61.8% |
| 2 | $121.00 | 1,323 | $160K | 38.2% |
| Total | $120.98 avg | 3,467 | $419K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |